Personnel

Bruce F. Mackler, PhD, JD, named to biopharm's HIV Scientific Advisory Board

Published in AIDS Weekly, December 13th, 2004

The Immune Response Corporation (IMNR), a biopharmaceutical company focused on immune-based therapy in HIV and multiple sclerosis, announced that Bruce Mackler, PhD, JD, an immunologist/immunochemist, has joined the company's HIV Scientific Advisory Board (SAB).

Mackler brings more than 25 years' experience in regulatory affairs to the board. He is a U.S. Food & Drug Administration (FDA) practice shareholder with the law firm of Heller Ehrman White & McAuliffe LLP, and an immunologist/immunochemist with some 100 published scientific articles/abstracts.

Mackler received his JD from the South Texas College of Law (magna cum laude, 1979), his PhD...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2004-12-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry